Mimedx (MDXG) Shares Outstanding (2010 - 2026)

Mimedx has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $145.7 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 1.49% year-over-year to $145.7 million; the TTM figure through Jun 2026 stood at $145.7 million (down 1.49% YoY), while the FY2025 annual figure was $148.1 million, up 0.79% from the prior year.
• Shares Outstanding (Entity) came in at $145.7 million for Q2 2026 at Mimedx, down from $148.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $148.9 million in Q1 2026 to a low of $113.4 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $133.0 million, with a median of $146.2 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) increased 27.86% in 2024 and declined 1.49% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $113.7 million in 2022, then rose by 2.45% to $116.5 million in 2023, then gained by 26.13% to $146.9 million in 2024, then advanced by 0.79% to $148.1 million in 2025, then retreated by 1.6% to $145.7 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $145.7 million in Q2 2026, $148.9 million in Q1 2026, and $148.1 million in Q4 2025.